Press Releases Immuron Limited

Equities

Market Closed - Australian S.E. Other stock markets 07:10:14 09/05/2024 BST			5-day change	1st Jan Change
0.09 ^AUD	-7.22%		-14.29%	+16.88%

05-03	Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director	CI
04-10	Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	CI

Immuron Limited to Present at the Emerging Growth Conference	05-07	GL
Immuron Director Resignation	05-03	GL
Immuron Director Resignation	05-03	AQ
Immuron to host Live Virtual Event	04-15	GL
Immuron Travelan® sales continued strong growth	04-10	GL
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	03-07	GL
Immuron Presentation Australian Biologics Festival 2024	02-21	GL
Immuron Presentation Australian Biologics Festival 2024	02-21	AQ
Immuron achieves record Travelan® sales	02-13	GL
Immuron achieves record Travelan® sales	02-13	AQ
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	02-08	GL
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	02-08	AQ
Immuron achieves record half yearly Travelan® sales	01-16	GL
Immuron Clinical Trials Update	12-22	GL
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	12-04	GL
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	12-04	AQ
Immuron CEO, Steven Lydeamore Investor Webinar Presentation	11-28	GL
Immuron CEO Steven Lydeamore Investor Webinar Presentation	11-13	GL
Immuron CEO Steven Lydeamore Investor Webinar Presentation	11-13	AQ
Immuron CEO Steven Lydeamore presented at AusBioInvest	30/10/23	GL

No results for this search